Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Integrated Phase II/III Randomized Control Trial of Transarterial Chemoembolisation Alone or in Combination With Stereotactic Body Radiation in Patients With Unresectable Hepatocellular Cancer

NCT02794337 is registered in ClinicalTrials.gov with Tata Memorial Hospital as lead sponsor.

NCT NCT02794337
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02794337 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Integrated Phase II/III Randomized Control Trial of Transarterial Chemoembolisation Alone or in Combination With Stereotactic Body Radiation in Patients With Unresectable Hepatocellular Cancer
Lead sponsor
Tata Memorial Hospital
Phase
Phase 2/3
Overall status
Unknown status
Start date
December 31, 2014
Completion date
January 31, 2024
Enrollment
67 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, hepatocellular